Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Oil Spill Accountability and Environmental Protection Act of 2010
Client: GENENTECH · Firm: SIDLEY AUSTIN LLP
Issues relating to patent law and patent procedure; S. 1145 and HR. 1908 (Patent Reform Act of 2007), S. 623 (Access to Life-Saving Medicine Act), HR. 5629 (Pathways and Biosimilars Act)
Oil Spill Accountability and Environmental Protection Act of 2010
Client: GENENTECH · Firm: SIDLEY AUSTIN LLP
Issues relating to patent law and patent procedure; S. 1145 and HR. 1908 (Patent Reform Act of 2007), S. 623 (Access to Life-Saving Medicine Act), HR. 5629 (Pathways and Biosimilars Act)
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
GENENTECH via SIDLEY AUSTIN LLP
2010 · second_quarter · Q2
H.R. 3590 (Patient Protection and Affordable Care Act of 2010)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENENTECH via SIDLEY AUSTIN LLP
2010 · first_quarter · Q1
Source: Senate LDA
Oil Spill Accountability and Environmental Protection Act of 2010
Client: GENENTECH · Firm: SIDLEY AUSTIN LLP
Issues relating to patent law and patent procedure; S. 1145 and HR. 1908 (Patent Reform Act of 2007), S. 623 (Access to Life-Saving Medicine Act), HR. 5629 (Pathways and Biosimilars Act)
Oil Spill Accountability and Environmental Protection Act of 2010
Client: GENENTECH · Firm: SIDLEY AUSTIN LLP
Issues relating to patent law and patent procedure: S. 1145 and H.R. 1908 (Patent Reform Act of 2007), S. 623 (Access to Life-Saving Medicine Act), H.R. 5629 (Pathways and Biosimilars Act)
Oil Spill Accountability and Environmental Protection Act of 2010
Client: GENENTECH · Firm: SIDLEY AUSTIN LLP
Issues relating to patent law and patent procedure; S. 1145 and HR. 1908 (Patent Reform Act of 2007), S. 623 (Access to Life-Saving Medicine Act), HR. 5629 (Pathways to Biosimilars Act)
Oil Spill Accountability and Environmental Protection Act of 2010
Client: GENENTECH · Firm: SIDLEY AUSTIN LLP
Issues relating to patent law and patent procedure; S. 1145 and HR. 1908 (Patent Reform Act of 2007), S. 623 (Access to Life-Saving Medicine Act), HR. 5629 (Pathways and Biosimilars Act)
Oil Spill Accountability and Environmental Protection Act of 2010
Client: GENENTECH · Firm: SIDLEY AUSTIN LLP
Issues relating to patent law and patent procedure; S. 1145 and HR. 1908 (Patent Reform Act of 2007), S. 623 (Access to Life-Saving Medicine Act), HR. 5629 (Pathways and Biosimilars Act)
Issues relating to patent law and patent procedure; S. 1145 and HR. 1908 (Patent Reform Act of 2007), S. 623 (Access to Life-Saving Medicine Act), HR. 5629 (Pathways and Biosimilars Act)
Issues relating to patent law and patent procedure; S. 1145 and HR. 1908 (Patent Reform Act of 2007), S. 623 (Access to Life-Saving Medicine Act), HR. 5629 (Pathways and Biosimilars Act)
Issues relating to patent law and patent procedure; S. 1145 and HR. 1908 (Patent Reform Act of 2007), S. 623 (Access to Life-Saving Medicine Act), HR. 5629 (Pathways and Biosimilars Act)
Issues relating to patent law and patent procedure; S. 1145 and HR. 1908 (Patent Reform Act of 2007), S. 623 (Access to Life-Saving Medicine Act), HR. 5629 (Pathways and Biosimilars Act)
Issues relating to patent law and patent procedure; S. 1145 and HR. 1908 (Patent Reform Act of 2007), S. 623 (Access to Life-Saving Medicine Act), HR. 5629 (Pathways to Biosimilars Act)
Issues relating to patent law and patent procedure: S. 1145 and H.R. 1908 (Patent Reform Act of 2007), S. 623 (Access to Life-Saving Medicine Act), H.R. 5629 (Pathways and Biosimilars Act)
Issues relating to patent law and patent procedure; S. 1145 and HR. 1908 (Patent Reform Act of 2007), S. 623 (Access to Life-Saving Medicine Act), HR. 5629 (Pathways and Biosimilars Act)
Issues relating to patent law and patent procedure; S. 1145 and HR. 1908 (Patent Reform Act of 2007), S. 623 (Access to Life-Saving Medicine Act), HR. 5629 (Pathways to Biosimilars Act)
Issues relating to patent law and patent procedure; S. 1145 and HR. 1908 (Patent Reform Act of 2007), S. 623 (Access to Life-Saving Medicine Act), HR. 5629 (Pathways and Biosimilars Act)
Issues relating to patent law and patent procedure; S. 1145 and HR. 1908 (Patent Reform Act of 2007), S. 623 (Access to Life-Saving Medicine Act), HR. 5629 (Pathways and Biosimilars Act)
Issues relating to patent law and patent procedure; S. 1145 and HR. 1908 (Patent Reform Act of 2007), S. 623 (Access to Life-Saving Medicine Act), HR. 5629 (Pathways and Biosimilars Act)
Issues relating to patent law and patent procedure: S. 1145 and H.R. 1908 (Patent Reform Act of 2007), S. 623 (Access to Life-Saving Medicine Act), H.R. 5629 (Pathways and Biosimilars Act)
Issues relating to patent law and patent procedure; S. 1145 and HR. 1908 (Patent Reform Act of 2007), S. 623 (Access to Life-Saving Medicine Act), HR. 5629 (Pathways and Biosimilars Act)
Issues relating to patent law and patent procedure; S. 1145 and HR. 1908 (Patent Reform Act of 2007), S. 623 (Access to Life-Saving Medicine Act), HR. 5629 (Pathways and Biosimilars Act)
Issues relating to patent law and patent procedure: S. 1145 and H.R. 1908 (Patent Reform Act of 2007), S. 623 (Access to Life-Saving Medicine Act), H.R. 5629 (Pathways and Biosimilars Act)
Issues relating to patent law and patent procedure; S. 1145 and HR. 1908 (Patent Reform Act of 2007), S. 623 (Access to Life-Saving Medicine Act), HR. 5629 (Pathways and Biosimilars Act)
Issues relating to patent law and patent procedure; S. 1145 and HR. 1908 (Patent Reform Act of 2007), S. 623 (Access to Life-Saving Medicine Act), HR. 5629 (Pathways and Biosimilars Act)
Issues relating to patent law and patent procedure; S. 1145 and HR. 1908 (Patent Reform Act of 2007), S. 623 (Access to Life-Saving Medicine Act), HR. 5629 (Pathways to Biosimilars Act)
Issues relating to patent law and patent procedure; S. 1145 and HR. 1908 (Patent Reform Act of 2007), S. 623 (Access to Life-Saving Medicine Act), HR. 5629 (Pathways and Biosimilars Act)
Issues relating to patent law and patent procedure; S. 1145 and HR. 1908 (Patent Reform Act of 2007), S. 623 (Access to Life-Saving Medicine Act), HR. 5629 (Pathways and Biosimilars Act)
Issues relating to patent law and patent procedure; S. 1145 and HR. 1908 (Patent Reform Act of 2007), S. 623 (Access to Life-Saving Medicine Act), HR. 5629 (Pathways and Biosimilars Act)
Issues relating to patent law and patent procedure; S.1145 and HR.1908 (Patent Reform Act of 2007), S.623 (Access to Life-Saving Medicine Act), HR.5629 (Pathways to Biosimilars Act)
Issues relating to patent law and patent procedure; S.1145 and HR.1908 (Patent Reform Act of 2007), S. 623 (Access to Life-Saving Medicine Act), HR.5629 (Pathways to Biosimilars Act)
Issues relating to patent law and patent procedure; S.1145 and HR.1908 (Patent Reform Act of 2007), S. 623 (Access to Life-Saving Medicine Act), HR.5629 (Pathways to Biosimilars Act)
Issues relating to patent law and patent procedure; S.1145 and HR.1908 (Patent Reform Act of 2007), S.623 (Access to Life-Saving Medicine Act), HR.5629 (Pathways to Biosimilars Act)
Issues relating to patent law and patent procedure; S.1145 and HR.1908 (Patent Reform Act of 2007), S.623 (Access to Life-Saving Medicine Act), HR.5629 (Pathways to Biosimilars Act)
Issues relating to patent law and patent procedure; S.1145 and HR.1908 (Patent Reform Act of 2007), S. 623 (Access to Life-Saving Medicine Act), HR.5629 (Pathways to Biosimilars Act)
Issues relating to patent law and patent procedure; S.1145 and HR.1908 (Patent Reform Act of 2007), S. 623 (Access to Life-Saving Medicine Act), HR.5629 (Pathways to Biosimilars Act)
Issues relating to patent law and patent procedure; S.1145 and HR.1908 (Patent Reform Act of 2007), S.623 (Access to Life-Saving Medicine Act), HR.5629 (Pathways to Biosimilars Act)
H.R. 3590 (Patient Protection and Affordable Care Act of 2010
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENENTECH via SIDLEY AUSTIN LLP
2009 · fourth_quarter · Q4
Issues relating to patent law and patent procedure: S. 1145 and H.R. 1908 (Patent Reform Act of 2007), S. 623 (Access to Life-Saving Medicine Act), H.R. 5629 (Pathways and Biosimilars Act)
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE
GENENTECH via SIDLEY AUSTIN LLP
2009 · third_quarter · 3A
Issues relating to patent law and patent procedure; S. 1145 and HR. 1908 (Patent Reform Act of 2007), S. 623 (Access to Life-Saving Medicine Act), HR. 5629 (Pathways and Biosimilars Act)
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE
GENENTECH via SIDLEY AUSTIN LLP
2009 · third_quarter · Q3
Issues relating to patent law and patent procedure; S. 1145 and HR. 1908 (Patent Reform Act of 2007), S. 623 (Access to Life-Saving Medicine Act), HR. 5629 (Pathways and Biosimilars Act)
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE
GENENTECH via SIDLEY AUSTIN LLP
2009 · third_quarter · Q3
Issues relating to patent law and patent procedure; S. 1145 and HR. 1908 (Patent Reform Act of 2007), S. 623 (Access to Life-Saving Medicine Act), HR. 5629 (Pathways and Biosimilars Act)
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE
GENENTECH via SIDLEY AUSTIN LLP
2009 · third_quarter · Q3
Issues relating to patent law and patent procedure; S. 1145 and HR. 1908 (Patent Reform Act of 2007), S. 623 (Access to Life-Saving Medicine Act), HR. 5629 (Pathways and Biosimilars Act)
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE
GENENTECH via SIDLEY AUSTIN LLP
2009 · second_quarter · Q2
Issues relating to patent law and patent procedure; S. 1145 and HR. 1908 (Patent Reform Act of 2007), S. 623 (Access to Life-Saving Medicine Act), HR. 5629 (Pathways and Biosimilars Act)
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE
GENENTECH via SIDLEY AUSTIN LLP
2009 · first_quarter · Q1
Issues relating to patent law and patent procedure; S. 1145 and HR. 1908 (Patent Reform Act of 2007), S. 623 (Access to Life-Saving Medicine Act), HR. 5629 (Pathways to Biosimilars Act)
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE
GENENTECH via SIDLEY AUSTIN LLP
2008 · fourth_quarter · Q4
Issues relating to patent law and patent procedure; S.1145 and HR.1908 (Patent Reform Act of 2007), S. 623 (Access to Life-Saving Medicine Act), HR.5629 (Pathways to Biosimilars Act)
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE
GENENTECH via SIDLEY AUSTIN LLP
2008 · third_quarter · Q3
Issues relating to patent law and patent procedure; S.1145 and HR.1908 (Patent Reform Act of 2007), S.623 (Access to Life-Saving Medicine Act), HR.5629 (Pathways to Biosimilars Act)
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE
GENENTECH via SIDLEY AUSTIN LLP
2008 · second_quarter · Q2
Issues relating to patent law and patent procedure
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE
GENENTECH via SIDLEY AUSTIN LLP
2008 · first_quarter · Q1
Issues relating to patent law and patent procedure
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE
GENENTECH via SIDLEY AUSTIN LLP
2007 · year_end · YA
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE
GENENTECH via SIDLEY AUSTIN LLP
2007 · year_end · YA
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE
GENENTECH via SIDLEY AUSTIN LLP
2007 · year_end · YA
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE
GENENTECH via SIDLEY AUSTIN LLP
2007 · year_end · YA
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE
GENENTECH via SIDLEY AUSTIN LLP
2007 · year_end · YA
Issues relating to patent law and patent procedure
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, UNDETERMINED
GENENTECH via SIDLEY AUSTIN LLP
2007 · year_end · YY
Issues relating to patent law and patent procedure
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE
GENENTECH via SIDLEY AUSTIN LLP
2007 · mid_year · MM
Issues relating to patent law and patent procedure.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE
GENENTECH via SIDLEY AUSTIN LLP
2006 · year_end · YA
Issues relating to patent law and patent procedure
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE
GENENTECH via SIDLEY AUSTIN LLP
2006 · year_end · YY
Issues relating to patent law and patent procedure
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE
GENENTECH via SIDLEY AUSTIN LLP
2006 · mid_year · MM
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE
GENENTECH via SIDLEY AUSTIN LLP
2005 · year_end · YY
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE
GENENTECH via SIDLEY AUSTIN LLP
2005 · mid_year · MM
Issues relating to patent law and patent procedure.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE
GENENTECH via SIDLEY AUSTIN LLP
2004 · year_end · YY
Issues relating to patent law and patent procedure.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE
IBM COPORATION via SIDLEY AUSTIN LLP
2003 · year_end · YY
Filing targets: Commerce, Dept of (DOC), Patent & Trademark Office (PTO)
GENENTECH via SIDLEY AUSTIN LLP
2003 · year_end · YY
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE
IBM COPORATION via SIDLEY AUSTIN LLP
2003 · mid_year · MM
Filing targets: Commerce, Dept of (DOC), Patent & Trademark Office (PTO)
BIOTECHNOLOGY INDUSTRY ORGANIZATION via SIDLEY AUSTIN LLP
2003 · mid_year · MM
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
GENENTECH via SIDLEY AUSTIN LLP
2003 · mid_year · MM
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE
BIOTECHNOLOGY INDUSTRY ORGANIZATION via SIDLEY AUSTIN LLP
2002 · year_end · YY
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
IBM COPORATION via SIDLEY AUSTIN LLP
2002 · year_end · YY
Filing targets: Commerce, Dept of (DOC), Patent & Trademark Office (PTO)
GENENTECH via SIDLEY AUSTIN LLP
2002 · year_end · YY
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE
BIOTECHNOLOGY INDUSTRY ORGANIZATION via SIDLEY AUSTIN LLP
2002 · mid_year · MM
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA via SIDLEY AUSTIN LLP
2002 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
GENENTECH via SIDLEY AUSTIN LLP
2002 · mid_year · MM
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE
GENENTECH via SIDLEY AUSTIN LLP
2002 · year_end · RR
BIOTECHNOLOGY INDUSTRY ORGANIZATION via SIDLEY AUSTIN LLP
2002 · year_end · RR